about
Effects of free fatty acids on plasma resistin and insulin resistance in awake ratsEfficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-AnalysisEffects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus.Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance.Circulating Zbed3 Levels in Subjects With and Without Metabolic Syndrome.Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults.Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin.Overexpression of JAZF1 protected ApoE-deficient mice from atherosclerosis by inhibiting hepatic cholesterol synthesis via CREB-dependent mechanisms.Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion.Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo.Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: possible role of the resistin and adiponectin.Potassium measurements and risk of type 2 diabetes: a dose-response meta-analysis of prospective cohort studies.Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance.Circulating betatrophin is associated with insulin resistance in humans: cross-sectional and interventional studies in vivo and in vitro.Myonectin Predicts the Development of Type 2 Diabetes.DPP-4 Inhibitors Improve Diabetic Wound Healing via Direct and Indirect Promotion of Epithelial-Mesenchymal Transition and Reduction of Scarring.JAZF1 Inhibits Adipose Tissue Macrophages and Adipose Tissue Inflammation in Diet-Induced Diabetic Mice.Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgeryCirculating CTRP15 is a marker for the presence of metabolic syndromeMitochondrial glycerol 3-phosphate dehydrogenase promotes skeletal muscle regenerationJAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanismTERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet Cells in Type 2 DiabetesC1q/TNF-Related Protein5 (CTRP5) as a Biomarker to Predict Metabolic Syndrome and Each of Its ComponentsGut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathwayHigh-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levelsAssociation of adipose most abundant transcript 1 gene (apM1) with type 2 diabetes mellitus in a Chinese population: a meta-analysis of case-control studiesCirculating bone morphogenetic protein-9 levels are associated with hypertension and insulin resistance in humansCorrigendum to "TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet β Cells in Type 2 Diabetes"C1q/TNF-related protein-6 is associated with insulin resistance and the development of diabetes in Chinese populationDeficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Contributes to Hepatic SteatosisInhibition of Mitochondrial Calcium Overload by SIRT3 Prevents Obesity- or Age-Related Whitening of Brown Adipose TissueOsteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 PathwayCirculating complement-1q tumor necrosis factor-α-related protein isoform 5 levels are low in type 2 diabetes patients and reduced by dapagliflozinCirculating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young WomenDOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling
P50
Q28566125-5F017614-2FA0-4650-9A0F-F863C116818CQ28972373-A4E68EAE-7182-4F3A-AAEB-27FC6AB9145CQ34064416-521F5CD4-128C-4204-9D20-6408EE7C9D6AQ34477327-E21CDBA9-905C-4E32-A3F7-64E75C492D70Q38873629-41A4F201-5B28-467E-93E3-B89BB43C44A8Q40290462-C77B1110-6986-4E43-86E8-822F8759A8D6Q41402646-2F39813B-2D4B-48D0-8AE5-E1BA8E336B52Q41700048-46BAA26F-A097-4227-8E2D-B141BBA5ECB7Q44660109-8C949E25-A7D4-44E6-9F47-A9CEF2E34E61Q45923867-428F9754-8BC9-4269-848E-CAD28417DDFFQ46233278-DFC7D474-F16A-4BDC-AE61-A96EDCE91DA1Q46843129-A12D67E4-01D3-4A0F-B813-FC2B70002263Q47097609-41D654B6-8F57-4592-BC29-2A05956F74ACQ47106541-1C493517-5194-4A49-9F67-7D6B8EC30285Q47108186-F23C3946-16BD-4141-812B-980A783746C9Q47378609-DB4902A7-609F-4CC4-B981-0C5DD828A432Q49645431-DC55A931-DDED-45DD-8B66-B1C7F42DBA0FQ55065620-732DE0C4-D73A-478D-8624-8481464CFEF6Q57069665-7DBD001A-9467-4110-A77E-53B9639E5343Q57283516-3EFC5B72-2D42-4701-993C-A6C925D86715Q58616125-A441A99D-4573-426B-9790-DF61647DFAB5Q58699594-DC93A322-0B08-4FB9-B6A2-5D286943B614Q58780515-60BDD42E-EA5C-4123-8B89-053D06692818Q60313483-34A0CEBC-432C-439B-B184-FC2C3861B8D2Q61443673-2AD6D74A-FD61-4D20-AB1F-83CC0CAF1272Q79453212-C9F5BB9B-9197-43CE-94C8-A352C55E159CQ81546263-F468AC04-8CEA-43BD-A21D-58C42B3254C6Q88088574-959CB3B7-65E2-43CA-A12C-BAA907B69652Q89737537-6786345A-ADB3-4540-B049-D03081038CC6Q90796918-9D012997-298A-4EB9-8675-5A44766ACB88Q91089901-E55A7E78-2B8A-46F6-8A3A-B99F7D6410F4Q91233899-591369D1-1984-4862-B477-3F0AE45CC41EQ91774733-C8A64748-79FF-488C-8BF5-34B2234F6076Q91874985-DE5C4757-F8A8-4E9D-9C7C-A4D16A008FE5Q92186966-6B50D6C1-3E72-4918-A46C-437D01904550Q92305841-F1CB3D01-3EC6-4F0C-9066-D14872D6BABD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gangyi Yang
@ast
Gangyi Yang
@en
Gangyi Yang
@es
Gangyi Yang
@nl
type
label
Gangyi Yang
@ast
Gangyi Yang
@en
Gangyi Yang
@es
Gangyi Yang
@nl
prefLabel
Gangyi Yang
@ast
Gangyi Yang
@en
Gangyi Yang
@es
Gangyi Yang
@nl
P106
P31
P496
0000-0002-6458-6747